settled daily · #129

Daily #129 stock chart answers — November 10, 2026

Five anonymised historical charts were dealt to every player. The Monkey Index returned -0.29% across the same tape.

56 desks completed all five charts.

chart 1
NKE
Nike
+5.01%
5-DAY ANSWER
47% UP / 53% DOWNcrowd split · 57 calls
47% called itdirectional accuracy
2008-05-21historical decision date
-0.05%Monkey Index contribution

With Bear Stearns freshly rescued and oil climbing toward record highs, traders spent the spring of 2008 wondering whether squeezed shoppers would still pay up for premium trainers. Nike shrugged off the consumer gloom as the build-up to the Beijing Olympics gathered pace, and buyers kept pressing their advantage into the summer.

chart 2
KLAC
KLA
+9.24%
5-DAY ANSWER
60% UP / 40% DOWNcrowd split · 57 calls
60% called itdirectional accuracy
2021-03-19historical decision date
-0.09%Monkey Index contribution

With the global chip shortage stalling car factories in early 2021, foundries were racing to expand capacity and needed KLA's inspection gear to check every silicon wafer on the line. Even a late-winter wobble in tech stocks could not keep buyers away for long.

chart 3
XEL
Xcel Energy
-0.67%
5-DAY ANSWER
70% UP / 30% DOWNcrowd split · 57 calls
30% called itdirectional accuracy
2015-08-14historical decision date
+0.02%Monkey Index contribution

Traders spent the summer of 2015 braced for the Federal Reserve's first interest-rate rise in nearly a decade, a textbook headwind for dividend-paying utilities like Xcel Energy, yet a late-August market wobble sent money straight back into defensive power companies. The rally stalled here as the wider market shook, though Xcel was already beginning the decade-long pivot from coal to wind farms that would reshape the business.

chart 4
PFE
Pfizer
+5.21%
5-DAY ANSWER
80% UP / 20% DOWNcrowd split · 56 calls
80% called itdirectional accuracy
2005-12-14historical decision date
+0.05%Monkey Index contribution

Big Pharma spent late 2005 deeply out of favour, weighed down by painkiller safety scares and looming patent expiries on Pfizer's biggest blockbuster drugs. Bargain hunters finally stepped in off the lows, and the December relief bounce held.

chart 5
SRE
Sempra
-7.32%
5-DAY ANSWER
45% UP / 55% DOWNcrowd split · 56 calls
55% called itdirectional accuracy
2022-09-23historical decision date
-0.22%Monkey Index contribution

With Europe scrambling for American liquefied natural gas to replace Russian supply and investors hiding in utilities during the 2022 bear market, Sempra spent the summer climbing while the wider market struggled. By late September, surging bond yields finally caught up with dividend shares and broke the safe-haven trade.

Call today’s five charts before the reveal →

← Previous daily recap